Bleichroeder LP’s DiaMedica Therapeutics DMAC Stock Holding History

Bleichroeder LP’s Portfolio DMAC Stock Details DMAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.69M	Hold	382,317	–	–	0.48%	30
2026 Q1	$2.59M	Hold	382,317	–	–	0.45%	29
2025 Q4	$3.04M	Hold	382,317	–	–	0.54%	23
2025 Q3	$2.63M	Hold	382,317	–	–	0.51%	25
2025 Q2	$1.49M	Hold	382,317	–	–	0.37%	25
2025 Q1	$1.45M	Hold	382,317	–	–	0.39%	24
2024 Q4	$2.08M	Hold	382,317	–	–	0.52%	20
2024 Q3	$1.6M	Hold	382,317	–	–	0.43%	25
2024 Q2	$1.13M	Buy	382,317 +160,000	+72%	+$439K	0.34%	29
2024 Q1	$616K	Hold	222,317	–	–	0.15%	37
2023 Q4	$631K	Hold	222,317	–	–	0.14%	33
2023 Q3	$574K	Sell	222,317 -71,800	-24%	-$231K	0.14%	30
2023 Q2	$1.27M	Buy	+294,117	New	+$714K	0.26%	32

Other funds holding DMAC

CLG

Cooperman Leon G $3.55B AUM 41.85% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bleichroeder LP's DMAC Position: Q2 2026 in Review

Bleichroeder LP held its DiaMedica Therapeutics (DMAC) position steady in Q2 2026 at 382,317 shares worth $2.69M. The position accounts for 0.48% of the portfolio, ranked #30.

Bleichroeder LP first reported a position in DMAC in Q2 2023 and has held it in 13 quarters since. The position peaked at $3.04M in Q4 2025. 89 funds tracked by Wall St. Rank hold DMAC as of Q2 2026.

Bleichroeder LP held 382,317 shares of DiaMedica Therapeutics worth $2.69M as of Q2 2026.
Bleichroeder LP left its DiaMedica Therapeutics share count unchanged in Q2 2026.
DiaMedica Therapeutics made up 0.48% of Bleichroeder LP's portfolio in Q2 2026, its #30 holding.
Bleichroeder LP first reported a position in DiaMedica Therapeutics in Q2 2023 and has held it in 13 quarters since.
Bleichroeder LP's DiaMedica Therapeutics position peaked at $3.04M in Q4 2025.
89 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q2 2026.

Based on Bleichroeder LP's 13F filing for Q2 2026, filed 13 Aug 2026.